Ergoteles’s Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant CCVI.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,800
Closed -$175K 2133
2022
Q2
$175K Hold
17,800
0.01% 1375
2022
Q1
$177K Hold
17,800
0.01% 1027
2021
Q4
$177K Hold
17,800
0.01% 1063
2021
Q3
$179K Hold
17,800
0.01% 1035
2021
Q2
$180K Hold
17,800
﹤0.01% 1312
2021
Q1
$179K Buy
+17,800
New +$193K 0.01% 695

Other funds holding CCVI.U

Ergoteles's CCVI.U Position: Q3 2022 in Review

Ergoteles sold out of Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant (CCVI.U) in Q3 2022, closing a stake of 17,800 shares — an estimated $175K sold.

Ergoteles first reported a position in CCVI.U in Q1 2021 and held it in 6 quarters. The position peaked at $180K in Q2 2021. 28 funds tracked by Wall St. Rank hold CCVI.U as of Q3 2022.

  • Ergoteles reported no remaining Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 17,800 Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant shares in Q3 2022, an estimated $175K.
  • Ergoteles first reported a position in Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant in Q1 2021 and held it in 6 quarters.
  • Ergoteles's Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position peaked at $180K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.